Educational guide
Adipotide Dosage Protocol | PeptideDosages.com
Adipotide (10 mg Vial) Dosage Protocol Adipotide (10 mg Vial) Dosage Protocol Adipotide Dosage Chart Adipotide is dosed at 250 mcg–1 mg daily via subcutaneous injection in educational protocols. A 10 mg vial reconstituted with bacteriostatic water yields about
This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.
Adipotide (10 mg Vial) Dosage Protocol
Adipotide (10 mg Vial) Dosage Protocol
Adipotide Dosage Chart
Adipotide is dosed at 250 mcg–1 mg daily via subcutaneous injection in educational protocols. A 10 mg vial reconstituted with bacteriostatic water yields about 3.33 mg/mL. This information is for research and educational use only.
Reconstitute: Add 3.0 mL bacteriostatic water (max vial capacity) → ~3.33 mg/mL concentration.
Starting dose: 250 mcg once daily; gradual escalation by 250 mcg every 2 weeks as tolerated.
Easy measuring: At 3.33 mg/mL, 1 unit = 0.01 mL ≈ 33.33 mcg on a U‑100 insulin syringe.
Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles[5].
Adipotide is a synthetic peptidomimetic that targets prohibitin on blood vessels within white adipose tissue and delivers a pro‑apoptotic sequence to destroy those vessels[1][2], resulting in targeted fat mass reduction as fat cells lose their blood supply[8]. Preclinical studies showed notable weight loss in obese rodents and primates[1][9]; however, clinical development was discontinued after a Phase 1 trial due to safety concerns[3][4]. This educational protocol presents a cautious once‑daily subcutaneous titration approach with careful dose escalation.
Research context: For evidence on mechanisms, human and preclinical research, limitations, and safety, read Adipotide Peptide: Benefits, Uses, Side Effects, Dosage, and Research.
Standard / Gradual Approach (3 mL = ~3.33 mg/mL)
Weeks 1–2
250 mcg
7.5 units (0.08 mL)
Weeks 3–4
500 mcg
15 units (0.15 mL)
Weeks 5–6
750 mcg
22.5 units (0.23 mL)
Weeks 7–8
1000 mcg (1.0 mg)
30 units (0.30 mL)
Frequency: Inject once daily subcutaneously. This schedule uses the largest practical dilution (3.0 mL) and starts at a conservative dose with gradual escalation to mitigate potential renal side effects observed at higher doses in preclinical studies[1][2]. For ≤10‑unit (≤0.10 mL) administrations, consider 30‑ or 50‑unit insulin syringes for improved readability.
Reconstitution Steps
Draw 3.0 mL bacteriostatic water with a sterile syringe.
Inject slowly down the vial wall; avoid foaming.
Gently swirl/roll until dissolved (do not shake).
Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light[5].
Supplies Needed
Plan based on an 8–week cautious titration protocol with once‑daily administration.
Peptide Vials (Adipotide, 10 mg each):
8 weeks ≈ 4 vials
12 weeks ≈ 7 vials
16 weeks ≈ 10 vials
Insulin Syringes (U‑100):
Per week: 7 syringes (1/day)
8 weeks: 56 syringes
12 weeks: 84 syringes
16 weeks: 112 syringes
Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.
8 weeks (4 vials): 12 mL → 2 × 10 mL bottles
12 weeks (7 vials): 21 mL → 3 × 10 mL bottles
16 weeks (10 vials): 30 mL → 3 × 10 mL bottles
Alcohol Swabs: One for the vial stopper + one for the injection site each day.
Per week: 14 swabs (2/day)
8 weeks: 112 swabs → recommend 2 × 100‑count boxes
12 weeks: 168 swabs → recommend 2 × 100‑count boxes
16 weeks: 224 swabs → recommend 3 × 100‑count boxes